John Liddle

5.3k citations

87 papers · 2.3k indexed · h-index 27

Health, Toxicology and Mutagenesis top 1%
Molecular Biology
Organic Chemistry top 5%
Pharmacology top 2%
Cancer Research top 5%

Co-authors: Virlyn W. Burse Larry L. Needham John W. Huffman Philip J. Landrigan Jenny L. Wiley Billy R. Martin Renate D. Kimbrough Shu Yu
Topics: Toxic Organic Pollutants Impact (11 papers)Synthesis and Catalytic Reactions (8 papers)Carcinogens and Genotoxicity Assessment (8 papers)
Cited by: Health, Toxicology and Mutagenesis Biological Psychiatry Cancer Research
Journals: Science New England Journal of Medicine Proceedings of the National Academy of Sciences
Partner nations: United States United Kingdom France

In The Last Decade

John Liddle

84 papers receiving 2.1k citations

Peers

Countries citing papers authored by John Liddle

Since Specialization

Citations

This map shows the geographic impact of John Liddle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Liddle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Liddle more than expected).

Fields of papers citing papers by John Liddle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Liddle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Liddle. The network helps show where John Liddle may publish in the future.

Co-authorship network of co-authors of John Liddle

This figure shows the co-authorship network connecting the top 25 collaborators of John Liddle. A scholar is included among the top collaborators of John Liddle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Liddle. John Liddle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Kynurenine monooxygenase regulates inflammation during critical illness and recovery in experimental acute pancreatitis 2023 ·Cell Reports ·(unknown),Xiaozhong Zheng,(unknown),Lucile Neyton,(unknown),Iain Uings,John Liddle,J. Kenneth Baillie,George Just,Margaret Binnie,Natalie Homer,(unknown),James Baily,(unknown),Christos Skouras,O. James Garden,Scott P. Webster,John P. Iredale,Sarah Howie,Damian J. Mole	9
2	Bosutinib prevents vascular leakage by reducing focal adhesion turnover and reinforcing junctional integrity 2020 ·Journal of Cell Science ·(unknown),(unknown),(unknown),John Liddle,(unknown),Jaap D. van Buul,Robert H. Bates,Pieter R. Tuinman,(unknown),Stephan Huveneers,Harm Jan Bogaard,Victor W.M. van Hinsbergh,Peter L. Hordijk,Jurjan Aman	26
3	Structure guided drug design to develop kallikrein 5 inhibitors to treat Netherton syndrome 2019 ·Bioorganic & Medicinal Chemistry Letters ·Ann L. Walker,Ryan P. Bingham,(unknown),(unknown),Duncan S. Holmes,John Liddle,Oxana Polyakova,(unknown),Kathrine J. Smith,James H. Thorpe,(unknown),Gemma V. White,Robert J. Young,Alain Hovnanian	6
4	Evaluation of a crystallographic surrogate for kallikrein 5 in the discovery of novel inhibitors for Netherton syndrome 2019 ·Acta Crystallographica Section F Structural Biology Communications ·James H. Thorpe,(unknown),Kathrine J. Smith,Xiao Qing Lewell,(unknown),Gemma V. White,Oxana Polyakova,Pamela Nassau,Ann L. Walker,Duncan S. Holmes,Andrew C. Pearce,(unknown),John Liddle,Alain Hovnanian	2
5	Design and development of a series of borocycles as selective, covalent kallikrein 5 inhibitors 2019 ·Bioorganic & Medicinal Chemistry Letters ·Ann L. Walker,Alexis Denis,Ryan P. Bingham,Anne Bouillot,(unknown),(unknown),Duncan S. Holmes,Alain Laroze,John Liddle,Marie-Hélène Fouchet,(unknown),(unknown),Andrew C. Pearce,Oxana Polyakova,Kathrine J. Smith,Pamela J. Thomas,James H. Thorpe,Lionel Trottet,(unknown),Alain Hovnanian	6
6	Discovery of potent and selective Spleen Tyrosine Kinase inhibitors for the topical treatment of inflammatory skin disease 2018 ·Bioorganic & Medicinal Chemistry Letters ·Michael D. Barker,John Liddle,Francis Atkinson,David M. Wilson,Marion C. Dickson,César Ramírez-Molina,Huw D. Lewis,(unknown),D.O. Somers,Margarete Neu,Emma J. Jones,Robert J. Watson	18
7	Structural and mechanistic basis of differentiated inhibitors of the acute pancreatitis target kynurenine-3-monooxygenase 2017 ·Nature Communications ·Jonathan P. Hutchinson,Paul Rowland,(unknown),(unknown),Carl Haslam,Clare I. Hobbs,Duncan S. Holmes,Paul Homes,John Liddle,Damian J. Mole,Iain Uings,Ann L. Walker,Scott P. Webster,Christopher G. Mowat,Chun‐wa Chung	37
8	A practical drug discovery project at the undergraduate level 2013 ·Drug Discovery Today ·M. Jonathan Fray,Simon J. F. Macdonald,(unknown),(unknown),Jack A. Brown,Ian B. Campbell,Ian Churcher,Diane M. Coe,Anthony W. J. Cooper,(unknown),Gail Fisher,Graham G. A. Inglis,(unknown),John Liddle,Aoife C. Maxwell,Vipulkumar K. Patel,Stephen Swanson,(unknown)	11
9	Pyridyl-2,5-Diketopiperazines as Potent, Selective, and Orally Bioavailable Oxytocin Antagonists: Synthesis, Pharmacokinetics, and In Vivo Potency 2012 ·Journal of Medicinal Chemistry ·Alan D. Borthwick,John Liddle,(unknown),Anne M. Exall,C. Hamlett,Deirdre M. B. Hickey,Andrew M. Mason,Ian E. Smith,Fabrizio Nerozzi,Simon Peace,(unknown),(unknown),Michael Allen,P.M. Woollard,Mark Pullen,Timothy D. Westfall,Dinesh Stanislaus	54
10	Progress Towards the Development of Anti-Inflammatory Inhibitors of IKKβ 2009 ·Current Topics in Medicinal Chemistry ·Paul Bamborough,James F. Callahan,J.A. Christopher,Jeffrey K. Kerns,John Liddle,David D. Miller,Mary A. Morse,William L. Rumsey,(unknown)	21
11	Structure–activity relationships for 1′,1′-dimethylalkyl-Δ8-tetrahydrocannabinols 2003 ·Bioorganic & Medicinal Chemistry ·John W. Huffman,John R. Miller,John Liddle,Shu Yu,Brian F. Thomas,Jenny L. Wiley,Billy R. Martin	29
12	5-Aryl-pyrazolo[3,4-b]pyridines: potent inhibitors of glycogen synthase kinase-3 (GSK-3) 2003 ·Bioorganic & Medicinal Chemistry Letters ·Jason Witherington,Vincent Bordas,Stephen L. Garland,Deirdre M. B. Hickey,Robert J. Ife,John Liddle,Martin Saunders,David G. Smith,Robert W. Ward	95
13	Paradoxical Pharmacological Effects of Deoxy-Tetrahydrocannabinol Analogs Lacking High CB<sub>1</sub> Receptor Affinity 2002 ·Pharmacology ·Jenny L. Wiley,(unknown),Graeme Griffin,John Liddle,Shu Yu,John W. Huffman,Billy R. Martin	13
14	3-(1′,1′-Dimethylbutyl)-1-deoxy-Δ8-THC and related compounds: synthesis of selective ligands for the CB2 receptor 1999 ·Bioorganic & Medicinal Chemistry ·John W. Huffman,John Liddle,Shu Yu,(unknown),Mary E. Abood,Jenny L. Wiley,Billy R. Martin	248
15	Synthesis and pharmacology of the isomeric methylheptyl-Δ8-tetrahydrocannabinols 1998 ·Bioorganic & Medicinal Chemistry ·John W. Huffman,John Liddle,(unknown),Shu Yu,Billy R. Martin,Jenny L. Wiley	20
16	Enantioselective synthesis and pharmacology of 11-hydroxy-(1'S,2'R)-dimethylheptyl-Δ8-THC 1998 ·Bioorganic & Medicinal Chemistry Letters ·John Liddle,John W. Huffman,Jenny L. Wiley,Billy R. Martin	5
17	Evaluation of Potential Analytical Approach for Determination of Polychlorinated Biphenyls in Serum: Interlaboratory Study 1983 ·Journal of AOAC INTERNATIONAL ·Virlyn W. Burse,Larry L. Needham,Chester R. Lapeza,Margaret P. Korver,John Liddle,D D Bayse	6
18	Persistent liver lesions in rats after a single oral dose of polybrominated biphenyls (firemaster FF-1) and concomitant PBB tissue levels. 1978 ·Environmental Health Perspectives ·Renate D. Kimbrough,Virlyn W. Burse,John Liddle	45
19	Epidemiology and Pathology of a Tetrachlorodibenzodioxin Poisoning Episode 1977 ·Archives of Environmental Health An International Journal ·Renate D. Kimbrough,(unknown),John Liddle,Richard E. Cline,(unknown)	52
20	Hereditary cholinesterase deficiency: A report of a family with two rare genotypes 1977 ·Clinical Genetics ·Edward L. Baker,Ann L. Smrek,Renate D. Kimbrough,(unknown),Philip J. Landrigan,John Liddle	3

About John Liddle

John Liddle is a scholar working on Chemical Health and Safety, Biological Psychiatry and Health, Toxicology and Mutagenesis, having authored 87 papers that have together received 2.3k indexed citations. Recurring topics across this work include Toxic Organic Pollutants Impact (11 papers), Synthesis and Catalytic Reactions (8 papers) and Carcinogens and Genotoxicity Assessment (8 papers). The work is most often cited by research in Health, Toxicology and Mutagenesis (715 citations), Biological Psychiatry (70 citations) and Cancer Research (318 citations). John Liddle has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Virlyn W. Burse, Larry L. Needham, John W. Huffman, Philip J. Landrigan, Jenny L. Wiley, Billy R. Martin, Renate D. Kimbrough, Shu Yu, Mary E. Abood and Ann L. Smrek. Their work appears in journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact